Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Aug 27, 2024; 16(8): 2671-2678
Published online Aug 27, 2024. doi: 10.4240/wjgs.v16.i8.2671
Published online Aug 27, 2024. doi: 10.4240/wjgs.v16.i8.2671
Table 1 Comparison of demographic information between the two groups, n (%)
Group | n | Age (years) | BMI (kg/m2) | Sex | Years of education | ASA grade | |||
Male | Female | I | II | III | |||||
A | 59 | 71.4 ± 4.3 | 21.99 ± 1.90 | 39 (66.10) | 20 (33.90) | 4.88 ± 1.25 | 15 (25.42) | 28 (47.46) | 16 (27.12) |
B | 58 | 70.8 ± 4.5 | 22.20 ± 2.14 | 32 (54.24) | 26 (44.07) | 5.04 ± 1.64 | 20 (34.48) | 25 (43.1) | 13 (22.41) |
t/χ2 | 0.737 | -0.562 | 1.464 | -0.594 | 1.186 | ||||
P value | 0.462 | 0.576 | 0.264 | 0.554 | 0.553 |
Table 2 Comparison of disease information between the two groups, n (%)
Group | n | Systolic pressure (mmHg) | Diastolic pressure (mmHg) | Fasting blood glucose (mmol/L) | Heart rate (times/min) | Lesion diameter (cm) | TNM stage | ||
I | II | III | |||||||
A group | 59 | 124.0 ± 6.8 | 76.5 ± 7.2 | 6.15 ± 0.64 | 78.8 ± 7.2 | 4.48 ± 1.40 | 17 (28.81) | 32 (54.24) | 9 (15.25) |
B group | 58 | 122.6 ± 6.2 | 78.5 ± 8.0 | 6.28 ± 0.71 | 80.4 ± 8.1 | 4.81 ± 1.67 | 11 (18.97) | 34 (58.62) | 14 (24.14) |
t/χ2 | 1.163 | -1.422 | -1.041 | -1.130 | -1.159 | 2.425 | |||
P value | 0.247 | 0.158 | 0.300 | 0.261 | 0.249 | 0.297 |
Table 3 Comparison of operation and anesthetic dosage between the two groups (mean ± SD)
Group | n | Operation time (min) | Anesthesia time (min) | Bleeding volume (mL) | Dosage of propofol (mg) | Remifentanil dosage (μg) |
A | 59 | 167.9 ± 16.8 | 183.4 ± 15.0 | 277.5 ± 43.8 | 654.7 ± 67.0 | 866.4 ± 55.8 |
B | 58 | 170.5 ± 17.2 | 189.1 ± 17.4 | 273.8 ± 47.2 | 695.8 ± 74.1 | 913.0 ± 68.6 |
t | -0.827 | -1.899 | 0.440 | -3.148 | -4.034 | |
P value | 0.410 | 0.060 | 0.661 | 0.002 | 0.000 |
Table 4 Comparison of bispectral index and regional cerebral oxygen saturation values between the two groups (mean ± SD)
Index | Group | Before anesthesia induction | Immediately after tracheal intubation | 30 min after start of surgery | Immediately after extubation | 5 min after extubation |
rSO2 (%) | A (n = 59) | 73.40 ± 4.40 | 66.18 ± 2.94 | 67.40 ± 2.86 | 69.04 ± 3.10 | 72.26 ± 3.35 |
B (n = 58) | 74.53 ± 3.78 | 64.07 ± 3.11 | 64.67 ± 3.15 | 66.12 ± 3.76 | 71.54 ± 3.43 | |
t | -1.489 | 3.772 | 4.910 | 4.587 | 1.149 | |
P value | 0.139 | 0.000 | 0.000 | 0.000 | 0.253 | |
BIS | A (n = 59) | 93.78 ± 1.65 | 48.40 ± 2.44 | 51.73 ± 2.73 | 56.20 ± 3.45 | 89.76 ± 2.80 |
B (n = 58) | 93.16 ± 1.73 | 49.23 ± 2.61 | 52.50 ± 2.87 | 57.43 ± 3.61 | 88.72 ± 3.41 | |
t | 1.984 | -1.777 | -1.487 | -1.884 | 1.804 | |
P value | 0.050 | 0.078 | 0.140 | 0.062 | 0.074 |
Table 5 Comparison of glucose uptake rate and lactate production rate between the two groups (mean ± SD)
Index | Group | Before anesthesia induction | Immediately after tracheal intubation | 30 min after start of surgery | Immediately after extubation | 5 min after extubation |
GluER (μg/L) | A (n = 59) | 6.83 ± 0.21 | 6.77 ± 0.19 | 6.73 ± 0.21 | 6.75 ± 0.19 | 6.70 ± 0.20 |
B (n = 58) | 6.89 ± 0.25 | 6.43 ± 0.42 | 6.28 ± 0.48 | 6.29 ± 0.34 | 6.31 ± 0.33 | |
t | -1.407 | 5.657 | 6.589 | 9.054 | 7.746 | |
P value | 0.162 | 0.000 | 0.000 | 0.000 | 0.000 | |
LacPR (μg/L) | A (n = 59) | 4.41 ± 0.27 | 4.89 ± 0.30 | 5.10 ± 0.37 | 5.19 ± 0.35 | 4.94 ± 0.30 |
B (n = 58) | 4.35 ± 0.31 | 5.28 ± 0.41 | 5.43 ± 0.40 | 5.49 ± 0.38 | 5.21 ± 0.47 | |
t | 1.117 | -5.879 | -4.634 | -4.443 | -3.710 | |
P value | 0.266 | 0.000 | 0.000 | 0.000 | 0.000 |
Table 6 Comparison of serum S100β and neuron-specific enolase levels between the two groups (mean ± SD)
Group | n | S100β (ng/L) | NSE (ng/L) | ||
Before operation | 24 h after operation | Before operation | 24 h after operation | ||
A | 59 | 0.58 ± 0.15 | 0.96 ± 0.25 | 3.96 ± 0.88 | 5.27 ± 1.03 |
B | 58 | 0.53 ± 0.17 | 1.21 ± 0.29 | 3.84 ± 0.90 | 6.91 ± 1.27 |
t | 1.688 | -4.997 | 0.729 | -7.678 | |
P value | 0.094 | 0.000 | 0.467 | 0.000 |
Table 7 Comparison of incidence of cognitive dysfunction between the two groups, n (%)
Group | n | 1 d after operation | 3 d after operation | 5 d after operation | 7 d after operation |
A | 59 | 7 (11.86) | 7 (11.86) | 3 (5.08) | 1 (1.69) |
B | 58 | 16 (27.59) | 14 (24.14) | 11 (18.97) | 3 (5.17) |
χ2 | 4.577 | 2.992 | 5.350 | 1.071 | |
P value | 0.032 | 0.084 | 0.021 | 0.301 |
Table 8 Comparison of incidence of adverse reactions caused by anesthesia between the two groups
Group | n | Nausea | Vomiting | Bradycardia | Respiratory depression | Overall adverse reactions (%) |
A | 59 | 3 | 1 | 1 | 0 | 5 (8.47) |
B | 58 | 8 | 3 | 2 | 1 | 14 (24.14) |
χ2 | 5.275 | |||||
P value | 0.022 |
- Citation: Bu HM, Zhao M, Ma HM, Tian XP. Application value of dexmedetomidine in anesthesia for elderly patients undergoing radical colon cancer surgery. World J Gastrointest Surg 2024; 16(8): 2671-2678
- URL: https://www.wjgnet.com/1948-9366/full/v16/i8/2671.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i8.2671